香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或 完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該 等內容而引致的任何損失承擔任何責任。 * （ 於開曼群島註冊成立之有限公司） （股份代號：00480） 截至2025年3月31日止年度 之 全年業績公告 業績 HKR International Limited 香 港 興 業 國 際 集 團 有 限 公 司（「 本 公 司 」）董 事 會（「 董 事 會」）宣佈本公司及其附屬公司（「集團」）截至2025年3月31日止年度（「2025 財年」） 之經審核全年業績。 集團於2025財年之收入為1,753.4百萬港元，較去年之3,940.7百萬港元減少56%， 主要是由於預計在2025財年後方會有物業發展項目完成，以致2025財年的物業發 展收入減少。於去年內，位於中華人民共和國（「中國」）嘉興市的星逸園項目之收 入確認為21億港元，該收入在比較兩個年度的差別時相對顯著。集團於2025財年 錄得基礎溢利70.0百萬港元，而去年則為172.6百萬港元。本公司擁有人應佔虧損 為786.0百萬港元，較 ...

近期，瑞达期货发布公告称，该公司及相关责任人收到厦门证监局出具的《关于对瑞达期货股份有限公司采取出具警示函、责令处分有关人员和责令增加内 部合规检查次数措施的决定》和《关于对林志斌、葛昶、曾永红、杨明东采取出具警示函措施的决定》。 厦门证监局决定对瑞达期货采取出具警示函、责令处分有关人员和责令增加内部合规检查次数的监督管理措施，并根据《证券期货市场诚信监督管理办法》 将相关情况记入证券期货市场诚信档案。 同时，厦门证监局指出，林志斌作为瑞达期货董事长，葛昶作为总经理，曾永红作为财务总监，杨明东作为首席风险官，未按照相关规定履行勤勉尽责义 务，对前述行为负有责任。厦门证监局决定对林志斌、葛昶、曾永红、杨明东采取出具警示函的行政监管措施，并根据《证券期货市场诚信监督管理办法》 将相关情况记入证券期货市场诚信档案。 据悉，瑞达期货在当日还收到深交所下发的监管函。深交所指出，瑞达期货董事长林志斌、总经理葛昶、财务总监曾永红、首席风险官杨明东，未能恪尽职 守、履行忠实勤勉义务，违反了相关规定。 事实上，这并非瑞达期货首次因类似问题受罚。2024年以来，其已多次遭到监管处罚。2024 年4月，海南证监局对其海南分公司采取 ...

证券代码：300218 证券简称：安利股份 安徽安利材料科技股份有限公司投资者关系活动记录表 | | 特定对象调研□分析师会议 | | --- | --- | | 投资者关系活动 | □媒体采访业绩说明会 | | | □新闻发布会路演活动 | | 类别 | 现场参观 | | |  其他： 线上交流会议 | | 参与单位名称及 | 1、民生证券：李金凤； | | 人员姓名 | 2、华安基金：辛大伟。 | | 时间 | 年 月 日 2025 6 18 10:00-11:00 | | 地点 | 线上交流会议 | | 上市公司接待人 | 董事会秘书、副总经理：刘松霞 | | 员姓名 | 证券助理：高杰晶 | | | 一、主要问题及回答 | | | 1、关税对公司影响？ | | | 答：2025 年 4 月，美国实施的"对等关税"政策对公司有 | | | 一定影响，但影响有限、影响较小。主要原因有以下两个方面。 | | | 一是 2024 年，公司直接出口美国占比约 2.55%，影响较小。 | | | 此外，公司直接出口美国的产品差异化强，技术含量高，短期 | | 投资者关系活动 | 内美国客户难以在国际市场 ...

Jabil’s NYSE: JBL share price struggled with traction early in 2025, but the struggles are behind it. The Q3 results and guidance update reveal the long-anticipated boost from AI is here. The company cited strengths in the cloud, data center infrastructure, and capital equipment segments, along with improved guidance, indicating that these strengths will continue. Jabil TodayJBLJabil$196.42 +15.60 (+8.63%) 52-Week Range$95.85▼$203.90Dividend Yield0.16%P/E Ratio46.99Price Target$169.17Add to WatchlistAmong ...

Top-line results expected July 2025 as development of first-in-class OSA drug advancesNEW YORK and MELBOURNE, Australia, June 18, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing combination drug therapies for high-impact indications, is pleased to announce that it has achieved database lock for the RePOSA Phase 2 clinical trial of IHL-42X, its lead drug candidate for obstructive sleep apnoea (OSA), on schedu ...

$1.5 million contract builds on ten-year relationship with Del NorteRESTON, Va., June 18, 2025 (GLOBE NEWSWIRE) -- Bowman Consulting Group Ltd. (NASDAQ: BWMN), a national engineering services and program management firm, has been selected as the lead engineer for a $24 million municipal water system upgrade in the Town of Del Norte, Colorado—the town’s largest water infrastructure project to date. Under a $1.5 million contract, Bowman will deliver full design, construction administration and inspection serv ...

CHARLOTTE, N.C., June 18, 2025 /PRNewswire/ -- Nucor Corporation (NYSE: NUE) today announced guidance for its second quarter ending July 5, 2025. Nucor expects second quarter earnings to be in the range of $2.55 to $2.65 per diluted share. Nucor reported net earnings of $0.67 per diluted share in the first quarter of 2025 and $2.68 per diluted share in the second quarter of 2024.Second Quarter of 2025 CommentaryEarnings in the second quarter of 2025 are expected to increase across all three of our operating ...

Zefiro subsidiary P&G continues to work with government agencies as a trusted service provider for projects involving several aspects of environmental remediation.FORT LAUDERDALE, Fla., June 18, 2025 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB: ZEFIF) (the “Company”, “Zefiro”, or “ZEFI”) is pleased to announce that its wholly owned subsidiary, Plants & Goodwin, Inc. (“P&G”), has been selected as the prime contractor for a three-year Construction Manager at Risk (“CMA ...

Global Phase 3 BRAVE study will evaluate the efficacy and safety of omaveloxolone in children 2 to <16 years old with Friedreich ataxia, a rare neurodegenerative disorderBRAVE study will explore the potential of omaveloxolone to address the critical unmet need of the pediatric FA populationOmaveloxolone is currently marketed under the brand name SKYCLARYS® for the treatment of adults and adolescents aged 16 years and older affected by Friedreich ataxia CAMBRIDGE, Mass., June 18, 2025 (GLOBE NEWSWIRE) -- Bio ...

MONTREAL and LYON, France, June 18, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, is proud to announce that its French technology partner, NOVACIUM SAS ("Novacium"), has launched the industrial production of cylindrical lithium-ion battery cells incorporating its third-generation silicon-based anode material ("GEN3"). Following the press releases dated Ju ...